Please enable JavaScript to view advertisements.
×
App Icon
The Standard e-Paper
Smart Minds Choose Us
★★★★ - on Play Store
Download App

Personalised cancer vaccine cuts melanoma recurrence risk in trial

Acral lentigenous melanoma of the toe. Acral lentiginous melanoma of the left hallux (ALM), Clark index IV in a 69-year-old man. [AFP]

A personalised cancer vaccine has shown promising results in reducing the risk of melanoma returning or spreading after surgery.

This marks a potential breakthrough in the treatment of high-risk skin cancer.

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902